MIT Biotechnology Group

Koch Inst. Summer Symposium: Cancer Nanotech, June 15

On June 15, 2018, MIT’s Koch Institute for Integrative Cancer Research will present its 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies. Nanomedicine is a converging field of study in biology and engineering where scientists work at the molecular level to engineer innovative approaches to better detect, monitor, and treat cancer. Experts will discuss how nanotechnology can provide rapid and sensitive detection of cancer, as well as generate entirely novel and highly effective therapeutic agents. The symposium will also feature an industry panel to discuss the impact of nanomedicine on the future of cancer care.

REGISTER NOW! (Use your MIT, Broad, or Whitehead email address to receive the registration discount!)

from industry, universities, hospitals, and the press

Noubar Afeyan, PhD
Daniel Anderson, PhD
Rashid Bashir, PhD
Angela Belcher, PhD
Sangeeta Bhatia, MD, PhD
Michelle S. Bradbury, MD, PhD
Vladimir Bulović, PhD
Mark E. Davis, PhD
Sanjiv Sam Gambhir, MD, PhD
Paula Hammond, PhD
James R. Heath, PhD
Robert Langer, ScD
John Maraganore, PhD
Suzie H. Pun, PhD
Cristianne Rijcken, PhD
Rebecca Spalding
Ralph Weissleder, MD, PhD

Leave a Reply